ArticleBMC complementary medicine and therapies2025
Antiproliferative activities of phytochemicals isolated from the leaves of Dolichos kilimandischaricus (Harms) ex Taub. (Fabaceae) on Jurkat and HL-60 leukemic cells.
Article in BMC complementary medicine and therapies, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundNatural plant products represent one of the most productive sources of innovative lead drugs for the treatment of a wide range of ailments. Dolichos kilimandischaricus (Harms) ex Taub. (Fabaceae) root extracts have been traditionally used for the treatment of HPV-related cancers. The extracts from the plant have been previously shown to have antiproliferative effects on cancer cell lines. This study aimed to isolate, purify, and analyze the phytochemicals from the leaves of D. kilimandischaricus.
methodsPhytochemicals in the ethanol leaf extract were separated by column chromatography on silica gel. The structures of the compounds were elucidated using spectroscopic techniques, then compared with the reported spectral data. Cytotoxicity of the phytochemicals on HL-60 and Jurkat cells was assessed by the sulphorhodamine B (SRB) assay with chlorambucil as a positive control. Docking simulations were used to further understand the binding preferences of the isolated compounds.
resultsThe isolated compounds were identified as 3β-stigmasterol (1) and α-spinasterol (2). The results showed that both compounds were more potent against HL-60 cells than Jurkat cells, with IC
conclusionsTherefore, this study has identified some of the phytochemicals that may be responsible for the antiproliferative activity in D. kilimandischaricus. These phytochemicals may provide leads in the development of compounds for treating cancer and related neoplastic diseases. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.